Stephen J. Langley

Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma

Johan Kips, Brian O’Connor, Stephen J. Langley et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 496 citations

Asthma, Severe Persistent Asthma, Allergy Medicine +16

A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol

James F. Donohue, J.A. van Noord, Eric Bateman et al. · CHEST Journal · 2002 · 469 citations

Advanced Lung Disease, Health Status Changes, Pulmonary Medicine +4

Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study

Clare Murray, Ashley Woodcock, Stephen J. Langley et al. · The Lancet · 2006 · 352 citations

Asthma, Allergy, Allergy Medicine +8

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

Martin Brutsche, Ingrid Carlen Brutsche, Mohamed Munawar et al. · The Lancet · 2000 · 222 citations

Asthma, Medicine, Pharmacology +5

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction

César Villarán, Shane O’Neill, Arthur Helbling et al. · Journal of Allergy and Clinical Immunology · 1999 · 181 citations · Full text

Asthma, Allergy, Exercise Physiology +5